Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)

Overview of attention for article published in Trials, April 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)

Mentioned by

blogs: 1 blog
twitter: 14 X users

patent: 1 patent

Citations

dimensions_citation: 132 Dimensions

Readers on

mendeley: 270 Mendeley

Summary Blogs X Patents Dimensions citations

So far, Dimensions has found 132 publications that cite this research output.

132

The most recent citing publications are shown below. View all 132 publications that cite this research output on Dimensions.

Clinical Evidence for GLP-1 Receptor Agonists in Alzheimer’s Disease: A Systematic Review

Article in Journal of Alzheimer's Disease Reports (May 2024)

The Spectrum of Cerebral Small Vessel Disease Emerging Pathophysiologic Constructs and Management Strategies

Article in Neurologic Clinics (May 2024)

Liraglutide versus pramlintide in protecting against cognitive function impairment through affecting PI3K/AKT/GSK-3β/TTBK1 pathway and decreasing Tau hyperphosphorylation in high-fat diet- streptozocin rat model

Article in Pflügers Archiv - European Journal of Physiology (March 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.